Antibiotics used to treat cystic fibrosis significantly increase risk of permanent hearing loss

Study published in Journal of Cystic Fibrosis for the first time measures cumulative dosage over a patient's lifetime

By Erik Robinson February 24, 2017 Portland, Ore.

Downloads

Medication increases hearing loss in cystic fibrosis patients

A study by Angela Garinis, Ph.D., a senior research associate in the Oregon Hearing Research Center at OHSU (left) and Peter Steyger, Ph.D., a professor of otolaryngology/head and neck surgery in the OHSU School of Medicine was recently published, showing antibiotics used to treat cystic fibrosis over a patient's lifetime increases the risk of permanent hearing loss. (OHSU/Kristyna Wentz-Graff)

Angela Garinis, Ph.D. (OHSU)

Peter Steyger, Ph.D.

Peter Steyger, Ph.D., a professor of otolaryngology/head and neck surgery in the OHSU School of Medicine, February 9, 2017. (OHSU/Kristyna Wentz-Graff)

Medication increases hearing loss in cystic fibrosis patients

Audio interview with Angie Garinis, PhD

Lead author Angela Garinis, Ph.D., describes a new study that measures hearing loss associated with cumulative lifetime dosage of a powerful antibiotic often used to treat people with cystic fibrosis.